Natera to Present 35 Studies at ASCO, Extending Clinical Data Leadership in Oncology
Go back to Natera to Present 35 Studies at ASCO, Extending Clinical Data Leadership in Oncology| (NASDAQ: NTRA) | Delayed: 219.23 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $219.23 | 52 Week High | $13.80 | |||
| Open | $219.23 | 52 Week Low | $6.52 | |||
| Day High | $219.23 | P/E | N/A | |||
| Day Low | $219.23 | EPS | $0.00 | |||
| Volume | 633 | |||||

